Neuberger Berman Group’s PTC Therapeutics PTCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-16,364
| Closed | -$821K | – | 1851 |
|
|
2022
Q3 | $821K | Buy |
+16,364
| New | +$821K | ﹤0.01% | 1308 |
|
|
2021
Q2 | – | Sell |
-24,141
| Closed | -$1.14M | – | 1813 |
|
|
2021
Q1 | $1.14M | Sell |
24,141
-39,359
| -62% | -$1.86M | ﹤0.01% | 1284 |
|
|
2020
Q4 | $3.88M | Hold |
63,500
| – | – | ﹤0.01% | 975 |
|
|
2020
Q3 | $2.97M | Buy |
63,500
+2,500
| +4% | +$117K | ﹤0.01% | 978 |
|
|
2020
Q2 | $3.1M | Buy |
61,000
+6,000
| +11% | +$304K | ﹤0.01% | 911 |
|
|
2020
Q1 | $2.45M | Hold |
55,000
| – | – | ﹤0.01% | 899 |
|
|
2019
Q4 | $2.64M | Buy |
55,000
+3,800
| +7% | +$183K | ﹤0.01% | 968 |
|
|
2019
Q3 | $1.73M | Buy |
51,200
+5,300
| +12% | +$179K | ﹤0.01% | 1044 |
|
|
2019
Q2 | $2.07M | Buy |
45,900
+24,900
| +119% | +$1.12M | ﹤0.01% | 1024 |
|
|
2019
Q1 | $790K | Buy |
+21,000
| New | +$790K | ﹤0.01% | 1167 |
|
|
2016
Q1 | – | Sell |
-15,731
| Closed | -$510K | – | 1516 |
|
|
2015
Q4 | $510K | Buy |
+15,731
| New | +$510K | ﹤0.01% | 1269 |
|
|
2015
Q3 | – | Sell |
-13,213
| Closed | -$636K | – | 1569 |
|
|
2015
Q2 | $636K | Sell |
13,213
-8,517
| -39% | -$410K | ﹤0.01% | 1289 |
|
|
2015
Q1 | $1.32M | Sell |
21,730
-5,570
| -20% | -$339K | ﹤0.01% | 1161 |
|
|
2014
Q4 | $1.41M | Buy |
27,300
+6,400
| +31% | +$331K | ﹤0.01% | 1139 |
|
|
2014
Q3 | $919K | Buy |
+20,900
| New | +$919K | ﹤0.01% | 1265 |
|